Somapacitan in children born small for gestational age: a randomized controlled phase 3 trial.

Linglart A, Böttcher V, Højby M, Soltysik K, Longui CA, Silverman L, Kashimada K

Open source

DOI
10.1093/ejendo/lvag021
Published
2026 Mar 4
Container
European journal of endocrinology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ejendo/lvag021,
  title = {Somapacitan in children born small for gestational age: a randomized controlled phase 3 trial.},
  author = {Linglart A and Böttcher V and Højby M and Soltysik K and Longui CA and Silverman L and Kashimada K},
  year = {2026},
  journal = {European journal of endocrinology},
  doi = {10.1093/ejendo/lvag021},
  url = {https://doi.org/10.1093/ejendo/lvag021}
}

RIS

TY  - JOUR
TI  - Somapacitan in children born small for gestational age: a randomized controlled phase 3 trial.
AU  - Linglart A
AU  - Böttcher V
AU  - Højby M
AU  - Soltysik K
AU  - Longui CA
AU  - Silverman L
AU  - Kashimada K
PY  - 2026
JO  - European journal of endocrinology
DO  - 10.1093/ejendo/lvag021
UR  - https://doi.org/10.1093/ejendo/lvag021
ER  - 

APA

A, L., V, B., M, H., K, S., CA, L., L, S., & K, K. (2026). Somapacitan in children born small for gestational age: a randomized controlled phase 3 trial.. European journal of endocrinology. https://doi.org/10.1093/ejendo/lvag021

Source records